Home › NDC Lookup › RxCUI directory › RxCUI 197405

Betamethasone 0.0005 MG/MG Topical Ointment — RxCUI 197405

RxNorm drug concept · Semantic clinical drug
RxCUI 197405 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 21 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197405
Official nameBetamethasone 0.0005 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbetamethasone 0.05 % Topical Ointment; betamethasone dipropionate 0.05 % Topical Ointment; betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Ointment
FDA products mapped13
Package NDCs mapped21
Reported Medicaid activity (SDUD)76,039 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Betamethasone Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It calms inflammation and itching in skin conditions that respond to steroids. The ointment is for people 13 and older. Sernivo spray is used for plaque psoriasis.
  • Use it only on your skin, as directed. With the lotion, a few drops once or twice daily is rubbed in gently. Wash your hands afterward and keep it out of your eyes.
  • Stop once your skin is under control. The strong lotion is limited to 2 weeks. If you see no improvement in 2 weeks, check back with your doctor.
  • Burning, stinging, itching or pain where you apply it are the most common. Skin thinning can also happen. Call your doctor about vision changes or skin that gets worse.
📖 Read our full Betamethasone Topical guide →

🕸️ Concept Web — How Betamethasone 0.0005 MG/MG Topical Ointment Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Betamethasone 0.0005 MG/MG Topical Ointment RxCUI 197405

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Betamethasone 1514
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Betamethasone Topical Ointment 374614
    • Betamethasone Topical Product 1153804
    • Topical Ointment 316985
    • Topical Product 1151122
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Betamethasone 0.0005 MG/MG 330632

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Betamethasone 0.0005 MG/MG SCDC · 330632
  • Betamethasone Topical Ointment SCDF · 374614
  • Betamethasone Topical Product SCDG · 1153804

📦 FDA Products & Package NDCs

13 products · 21 package NDCs
21 package NDCs map to RxCUI 197405 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00168-0055-15 1 TUBE in 1 CARTON (0168-0055-15) / 15 g in 1 TUBE Betamethasone Dipropionate E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1984-06-26
00168-0055-46 1 TUBE in 1 CARTON (0168-0055-46) / 45 g in 1 TUBE Betamethasone Dipropionate E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1984-06-26
00168-0056-15 1 TUBE in 1 CARTON (0168-0056-15) / 15 g in 1 TUBE Betamethasone Dipropionate E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1984-09-04
00168-0056-46 1 TUBE in 1 CARTON (0168-0056-46) / 45 g in 1 TUBE Betamethasone Dipropionate E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1984-09-04
00168-0057-60 1 BOTTLE in 1 CARTON (0168-0057-60) / 60 mL in 1 BOTTLE Betamethasone Dipropionate E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 1985-08-12
00472-0381-15 1 TUBE in 1 CARTON (0472-0381-15) / 15 g in 1 TUBE Betamethasone Dipropionate Actavis Pharma, Inc. 1997-02-01
00472-0381-45 1 TUBE in 1 CARTON (0472-0381-45) / 45 g in 1 TUBE Betamethasone Dipropionate Actavis Pharma, Inc. 1997-02-01
45802-0505-14 1 TUBE in 1 CARTON (45802-505-14) / 15 g in 1 TUBE BETAMETHASONE DIPROPIONATE Padagis Israel Pharmaceuticals Ltd 2022-05-20
45802-0505-84 1 TUBE in 1 CARTON (45802-505-84) / 45 g in 1 TUBE BETAMETHASONE DIPROPIONATE Padagis Israel Pharmaceuticals Ltd 2022-05-20
50090-0236-00 1 TUBE in 1 CARTON (50090-0236-0) / 15 g in 1 TUBE Betamethasone Dipropionate A-S Medication Solutions 2016-06-29
52817-0824-15 1 TUBE in 1 CARTON (52817-824-15) / 15 g in 1 TUBE Betamethasone Dipropionate USP, 0.05% TruPharma LLC 2022-02-18
52817-0824-45 1 TUBE in 1 CARTON (52817-824-45) / 45 g in 1 TUBE Betamethasone Dipropionate USP, 0.05% TruPharma LLC 2022-02-18
63629-9323-01 1 TUBE in 1 CARTON (63629-9323-1) / 15 g in 1 TUBE BETAMETHASONE DIPROPIONATE Bryant Ranch Prepack 2022-07-07
63629-9324-01 1 TUBE in 1 CARTON (63629-9324-1) / 45 g in 1 TUBE BETAMETHASONE DIPROPIONATE Bryant Ranch Prepack 2022-07-07
70771-1550-01 1 TUBE in 1 CARTON (70771-1550-1) / 15 g in 1 TUBE betamethasone dipropionate Zydus Lifesciences Limited 2020-07-20
70771-1550-04 1 TUBE in 1 CARTON (70771-1550-4) / 45 g in 1 TUBE betamethasone dipropionate Zydus Lifesciences Limited 2020-07-20
71335-2715-01 1 TUBE in 1 CARTON (71335-2715-1) / 45 g in 1 TUBE BETAMETHASONE DIPROPIONATE Bryant Ranch Prepack 2025-07-28
72162-1415-02 1 TUBE in 1 CARTON (72162-1415-2) / 45 g in 1 TUBE BETAMETHASONE DIPROPIONATE Bryant Ranch Prepack 2024-03-12
72162-1415-04 1 TUBE in 1 CARTON (72162-1415-4) / 15 g in 1 TUBE BETAMETHASONE DIPROPIONATE Bryant Ranch Prepack 2024-03-12
72578-0093-01 1 TUBE in 1 CARTON (72578-093-01) / 15 g in 1 TUBE betamethasone dipropionate Viona Pharmaceuticals Inc 2020-07-20
72578-0093-06 1 TUBE in 1 CARTON (72578-093-06) / 45 g in 1 TUBE betamethasone dipropionate Viona Pharmaceuticals Inc 2020-07-20
Observed labelers: Bryant Ranch Prepack (5) · E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC (5) · Actavis Pharma, Inc. (2) · Padagis Israel Pharmaceuticals Ltd (2) · TruPharma LLC (2) · Viona Pharmaceuticals Inc (2) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.